Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
irinotecanhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|
irinotecanhydrochloridtrihydrat 20 mg/ml koncentrat til infusionsvæske, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|
irinotecanhydrochloridtrihydrat 20 mg/ml koncentrat til infusionsvæske, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|
Irinotecan hydrochloride 20mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|
Camptosar 20mg/ml injection 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|
Irinotecan hydrochloride 20mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|
Irinotecan hydrochloride 20mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|
irinotecanhydrochloridtrihydrat 20 mg/ml koncentrat til infusionsvæske, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|
irinotecanhydrochloridtrihydrat 20 mg/ml koncentrat til infusionsvæske, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|
irinotecanhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|
Irinotecan hydrochloride trihydrate (substance) |
Is a |
False |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|
Irinotecan hydrochloride trihydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|
Irinotecan hydrochloride anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Irinotecan hydrochloride (substance) |
Inferred relationship |
Some |
|